CLINICAL FEATURES AND LONG-TERM OUTCOMES OF PEDIATRIC DE NOVO ACUTE MYELOID LEUKEMIA IN CHINA WITH OR WITHOUT SPECIFIC GENE ABNORMALITIES: A RETROSPECTIVE STUDY OF PATIENTS TREATED ON BCH-AML 2005

EHA Library, Hongbo He, 421198

REVISITING THE REAL-WORLD PROGNOSIS OF INTENSIVE CHEMOTHERAPY IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS IN THE VENETOCLAX ERA.

EHA Library, Takeshi Hagino, 421199

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM PROGNOSTIC SCORE

EHA Library, Philip Haddad, 421200

VICEROY: A PHASE I/II STUDY OF GILTERITINIB, VENETOCLAX AND AZACITIDINE COMBINATION IN PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE INDUCTION CHEMOTHERAPY

EHA Library, Naval Daver, 421201

REAL WORLD DATA OF FLT3-MUTATED AML IN URUGUAY

EHA Library, Matilde Boada, 421202

GENOMIC CHARACTERIZATION ANALYSIS OF ACUTE MYELOID LEUKEMIA PATIENTS WITH T(8;21) VARIANT TRANSLOCATION

EHA Library, Bingbing Han, 421203

GENETIC ABNORMALITIES ASSOCIATED WITH OUTCOMES IN PATIENTS WITH NPM1-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Shunjie Yu, 421204

CLINICAL IMPLICATION OF RAS MUTATION IN LOW RISK PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Nadine Gebril, 421205

GERIATRIC FUNCTIONAL ASSESSMENT AS AN EARLY PROGNOSTIC TOOL FOR ELDERLY PATIENTS WITH MYELOID DISEASE: A PROSPECTIVE STUDY

EHA Library, Hyeoung-Joon Kim, 421206

EFFICACY AND TOLERABILITY OF COMBINED REGIMENS WITH MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR REFRACTORY AND RELAPSED ACUTE MYELOID LEUKEMIA

EHA Library, Li Liu, 421207

VENETOCLAX PLUS CACAG FOR REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA：A SINGLE-ARM，PHASE Ⅱ TRIAL

EHA Library, Yanan Wen, 421208

A FIRST-IN-HUMAN, PHASE 1, DOSE ESCALATION STUDY OF SGR-2921 AS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME

EHA Library, Pau Montesinos, 421209

VENETOCLAX ADDED TO CLAG REGIMEN IMPROVES THE OUTCOME OF PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Guopan YU, 421210

IN ACUTE MYELOID LEUKEMIA, RESPONSE TO VENETOCLAX COMBINATIONS PREDICTS COMPARABLE SURVIVAL IRRESPECTIVE OF THERAPEUTIC LINE

EHA Library, Alessandro Bosi, 421211

THE EFFICACY AND SAFETY OF SELINEXOR COMBINED WITH VENETOCLAX FOR UNTREATED ELDERLY UNFIT ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Fei Li, 421212

REAL WORD EXPERIENCE WITH VENETOCLAX-BASED THERAPY IN ACUTE MYELOID LEUKEMIA IN CZECH REPUBLIC

EHA Library, Barbora Dluhosova, 421213

EXPLORATION OF PROGNOSTIC FACTORS IN CHILDREN ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22.1) MOLECULAR CHARACTERISTICS AND TREATMENT OPTIONS

EHA Library, Xin Su, 421214

TRIPLET THERAPY WITH GILTERITINIB, VENETOCLAX, AND AZACITIDINE FOR RELAPSED/REFRACTORY FLT3MUT ACUTE MYELOID LEUKEMIA

EHA Library, Qiang Fu, 421215

EFFICACY AND SAFETY ANALYSIS OF AZACITIDINE THERAPY AFTER HAPLOIDENTICAL TRANSPLANTATION FOR PEDIATRIC ACUTE MYELOID LEUKEMIA PATIENTS WHO WERE MINIMAL RESIDUAL DISEASE-POSITIVE BEFORE TRANSPLANT

EHA Library, Huili Zhu, 421216

FEATURES AND PROGNOSTIC SIGNIFICANCE OF SOLUBLE TIM-3 AND ITS LIGANDS GAL-9 AND CEACAM1 LEVELS IN THE DIAGNOSTIC BONE MARROWS OF ADULT ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Ya-Zhen Qin, 421217

A COMPOSITION OF MULTI-MARKERS CAN HIGH EFFICIENTLY   SCREEN  ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Hui Wang, 421218

QUANTUM-FIRST: SAFETY BY TREATMENT (TX) PHASE AND BY AGE IN NEWLY DIAGNOSED (ND) PATIENTS WITH FMS-LIKE TYROSINE KINASE 3–INTERNAL TANDEM DUPLICATION (FLT3-ITD) POSITIVE ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Harry Erba, 421219

CONSTRUCTION AND VALIDATION OF AN ASSISTANT DECISION-MAKING MODEL FOR PLATELET TRANSFUSION REFRACTORINESS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Xiaowen Tang, 421220

VENETOCLAX PLUS HOMOHARRINGTONINE WITH CYTARABINE AND ACLARUBICIN AS INDUCTION THERAPY FOR YOUNG ADULTS WITH DE NOVO ACUTE MYELOID LEUKEMIA: A PROSPECTIVE, SINGLE-ARM, MULTICENTER, PHASE 2 STUDY

EHA Library, Huafeng Wang, 421221

A REAL-WORLD STUDY OF THE EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN TREATING PATIENTS WITH FAVORABLE-RISK ACUTE MYELOID LEUKEMIA

EHA Library, Qi Chen, 421222

PROPHYLACTIC THERAPY OF EPIGENETIC AGENTS IN HIGH-RISK AML WITH RUNX1-RUNXT1 AFTER ALLO-HSCT

EHA Library, Erlie Jiang, 421223

CHARACTERIZATION OF ADULT PATIENTS WITH CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA IN CHILE. RESULTS OF THE GRELAM-CHILE ON BEHALF OF THE AML EPIDEMIOLOGICAL REGISTRY FROM PETHEMA STUDY GROUP.

EHA Library, Monica Romero, 421224

THE CLINICAL EFFICACY OF DARATUMUMAB-BASED REGIMEN IN RELAPSED/REFRACTORY ACUTE LEUKEMIA A SINGLE CENTER RETROSPECTIVE STUDY

EHA Library, Jing Li, 421225

REAL-LIFE MOROCCAN EXPERIENCE OF VENETOCLAX, AZACITIDINE AND ANTIFUNGAL PROPHYLAXIS (VORICONAZOLE) IN AML AND HIGH-RISK MDS.

EHA Library, Amal Terfaï, 421226

EFFECTIVE PROGNOSTIC MODEL FOR THERAPY RESPONSE PREDICTION IN ACUTE MYELOID LEUKEMIA PATIENTS RECEIVED INDUCTION THERAPY WITH ANTHRACYCLINES

EHA Library, Maria Kolesnikova, 421228

AZACITIDINE AND VENETOCLAX THERAPY AND TUMOUR LYSIS RATES IN OXFORD UNIVERSITY HOSPITALS

EHA Library, Ashlyn Chee, 421230

EFFICACY AND SAFETY OF NOVEL THERAPY APPROACHES FOR ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY PATIENTS: UKRAINIAN PROSPECTIVE STUDY

EHA Library, Zinaida Stupakova, 421231

ROLE AND IMPACT OF NEXT GENERATION SEQUENCING IN AML TREATMENT IN RESOURCE CONSTRAINT SETTING- A SINGLE CENTRE EXPERIENCE FROM INDIA

EHA Library, PRATIBHA DHIMAN, 421232

A PROSPECTIVE STUDY OF ALL-TRANS RETINOIC ACID PLUS VENETOCLAX AND AZACITIDINE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Chengyuan Gu, 421233

PREDICTIVE ROLE OF PLATELETS RECOVERY IN THE SETTING OF ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH AZACITIDINE-VENETOCLAX

EHA Library, Natalia Cenfra, 421234

GENETIC ABNORMALITIES PREDICT OUTCOMES IN PATIENTS WITH CORE BINDING FACTOR ACUTE MYELOID LEUKEMIAS

EHA Library, Shunjie Yu, 421235

DEVELOPMENT OF A PHASE-I-TRIAL EVALUATING A MULTI-PEPTIDE VACCINE DIRECTED AGAINST ACUTE MYELOID LEUKEMIA STEM AND PROGENITOR CELLS

EHA Library, Susanne Jung, 421236

EFFECT OF SORAFENIB ON PROGNOSIS IN PATIENTS WITH LOW ALLELIC RATIO FLT3-ITD ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, qiannan Yang, 421237

RISK FACTORS FOR DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA DURING NOCYTOSTATIC THERAPY

EHA Library, Arina Semenova, 421238

ABC-14 REGIMEN (AZACITIDINE, VENETOCLAX AND CHIDAMIDE) IS COMPARABLE TO “3+7” REGIMEN IN DE NOVO AML: A REAL-WORLD EXPERIENCE FROM ABC-14 COLLABORATION GROUP

EHA Library, Ping Wu, 421239

RESULTS OF ALLOGENIC STEM CELL TRANSPLANTATION IN ADULT CHILEAN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA. ANALYSIS OF THE GRELAM-CHILE ON BEHALF OF THE AML REGISTRY FROM THE PETHEMA STUDY GROUP

EHA Library, Monica Romero, 421240

MULTICENTER EVALUATION OF TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL): RESULTS OF THE EPIDEMIOLOGICAL REGISTRY OF THE PETHEMA GROUP IN CHILE.

EHA Library, Yaima Gutierrez, 421241

OUTCOMES OF RELAPSED ACUTE MYELOID LEUKAEMIA IN CHILDREN: A MONOCENTRIC EXPERIENCE

EHA Library, Hanen Charfi, 421242

MAST CELL LEUKEMIA: A SEER REGISTRY- BASED ANALYSIS OF SURVIVAL OUTCOMES FROM 2000-2020

EHA Library, Sruthi Vellanki, 421243

VENETOCLAX COMBINATION THERAPIES IN PEDIATRIC PATIENTS WITH MYELOID NEOPLASMS: A MULTICENTER RETROSPECTIVE ANALYSIS

EHA Library, Alicia Pablos Lopez, 421244

INCIDENCE AND PREDISPOSING FACTORS OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE NON-PROMYELOCYTIC MYELOID LEUKEMIA: EXPERIENCE FROM TWO CENTERS

EHA Library, Vasiliki Gkalea, 421245

OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN FLT3-TKD POSITIVE ACUTE MYELOID LEUKAEMIA IN THE MIDOSTAURIN-BASED THERAPY ERA: A STUDY OF THE POLISH ADULT LEUKAEMIA GROUP (PALG)

EHA Library, Elzbieta Patkowska, 421246

CLINICAL OUTCOMES OF ADULT CHILEAN PATIENTS WITH SECONDARY ACUTE MYELOBLASTIC LEUKEMIA. RESULTS OF GRELAM-CHILE STUDY GROUP INTHE FRAMEWORK OF THE EPIDEMIOLOGICAL REGISTRY OF AML-PETHEMA.

EHA Library, Monica Romero, 421247

THE PREVALENCE OF INVASIVE ASPERGILLOSIS AND OUTCOME OF ANTIFUNGAL TREATMENT IN PATIENTS WITH ACUTE LEUKEMIA- SINGLE CENTRE EXPERIENCE

EHA Library, Ana Vidovic, 421248

REAL-WORLD USE OF VENETOCLAX + AZACITIDINE IN ELDERLY (> 70 YEARS) CHEMOTHERAPY-INELIGIBLE UNTREATED ACUTE MYELOID LEUKEMIA PATIENTS. A SECOND LEVEL HOSPITALS EXPERIENCE.

EHA Library, Carolina Villegas Da Ros, 421249

ORAL AZACITIDINE MAINTENANCE AFTER FRONT LINE TREATMENT WITH AZACITIDINE + VENETOCLAX IN ELDERLY AML PATIENTS: SINGLE CENTER EXPERIENCE

EHA Library, Hélène GARDENEY, 421250

VENETOCLAX AND AZACITIDINE AS FIRST LINE TREATMENT IN ACUTE MYELOID LEUKEMIA (AML): REAL-LIFE EXPERIENCE AND COMPLICATIONS

EHA Library, Reyes Maria Martin Rojas, 421251

HYPOMETHYLATING AGENTS + VENETOCLAX THERAPY IN LATE ELDERLY AML: “TO BE OR NOT TO BE” WELL EFFECTIVE?

EHA Library, Lorenzo Rizzo, 421252

AML-MYELODYSPLASIA RELATED [AML-MR]: CYTOGENETIC ABNORMALITIES, MOLECULAR PROFILE AND TREATMENT OUTCOMES IN NEWLY DEFINED AML SUBTYPE.

EHA Library, Sujeet Kumar, 421253

DIVERSITY OF GENE VARIANTS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Anastasia Kashlakova, 421254

REAL WORLD EXPERIENCE OF TREATMENT WITH CPX-351 COMPARED TO 3+7 FOR MYELODYSPLASIA RELATED AND TREATMENT RELATED ACUTE MYELOID LEUKEMIA IN A TERTIARY HOSPITAL IN SPAIN

EHA Library, Rodrigo Gil Manso, 421255

MN-PCTS POST PARP INHIBITOR TREATMENT : A SINGLE CENTER EXPERIENCE

EHA Library, Giannakas Konstantinos, 421256

AZACITIDINE WITH VENETOCLAX REDUCED TO 14-21 DAYS IN THE FIRST CYCLE DOES NOT NEGATIVELY IMPACT TREATMENT OUTCOMES.

EHA Library, Aleksandra Wadolowska, 421257

CLINICAL CHARACTERISTICS AND EVOLUTION OF CHILEAN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WITH NPM1 MUTATION. STUDY OF GRELAM-CHILE, ON BEHALF OF THE MULTICENTER REGISTRY OF PETHEMA

EHA Library, Monica Romero, 421258

SINGLE-CENTER REAL-LIFE EXPERIENCE OF TREATMENT OF ELDERLY PATIENTS (>65 YEARS OLD) WITH ACUTE MYELOID LEUKEMIA.

EHA Library, Karolina Bełdzińska-Gądek, 421259

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN): EXPERIENCE IN OUR CENTRE

EHA Library, Angel Horrillo Orejudo, 421260

EXTRAMEDULLARY RELAPSE OF AML AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CLINICAL MANIFESTATIONS, TREATMENT MODALITIES AND OUTCOME.

EHA Library, Giuliano Filippini Velazquez, 421261

SIGNIFICANCE OF PERIPHERAL BLOOD PARAMETERS AND PRIMARY HEMOSTASIS INDICATORS ON HEMORRHAGE COMPLICATIONS IN PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA (AML): UKRAINE PROSPECTIVE STUDY

EHA Library, Zinaida Stupakova, 421262

PROGNOSTIC ROLE OF C-REACTIVE PROTEIN, ALBUMIN AND THE GLASGOW PROGNOSTIC SCORE IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA NOT SUITABLE FOR INTENSIVE TREATMENT. A RETROSPECTIVE STUDY.

EHA Library, Tobias Silzle, 421263

PRECISION THERAPY FOR ELDERLY ACUTE MYELOID LEUKAEMIA PATIENTS. 5-AZA – VENETOCLAX AS A PARADIGM?

EHA Library, Harberth Fernandez-Leyva, 421264

DYSPLASIA ASSESSMENT AT THE AML DIAGNOSIS (PRIMARY VS SECONDARY?). A SINGLE INSTITUTION EXPERIENCE.

EHA Library, Harberth Fernandez-Leyva, 421265

CLINICAL AND MOLECULAR PROFILE AND INDUCTION OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH CONVENTIONAL CHEMOTHERAPY AND VENETOCLAX-HMA BASED REGIMEN

EHA Library, Deep Gala, 421266

MIDOSTAURIN IN ASSOCIATION TO AZACITIDINE+/- VENETOCLAX IN ELDERLY FLT3-MUTATED AML PATIENTS: SINGLE CENTER EXPERIENCE

EHA Library, Hélène GARDENEY, 421267

ALTERATIONS IN NUTRITIONAL STATUS AMONG PATIENTS RECEIVING INTENSIVE HEMATOLOGICAL THERAPY – PILOT STUDY

EHA Library, Ewa Zarzycka, 421268

HIGH CHIMERIC TRANSCRIPT LEVEL AFTER FIRST INDUCTION CYCLE PREDICTS AN EARLY RELAPSE IN ADULT AML CBFB::MYH11 PATIENTS

EHA Library, Andrey Sokolov, 421269

MOLECULAR GENETIC PROFILE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA IN THE REPUBLIC OF BELARUS

EHA Library, Aliaksandra Marchanka, 421270

RETROSPECTIVE OBSERVATIONAL STUDY TO DESCRIBE THE PROFILE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) NOT SUITABLE FOR INTENSIVE CHEMOTHERAPY TREATMENT IN SPAIN. UNFIT STUDY

EHA Library, Ana Luisa Gobartt Vazquez, 421272

ACUTE MYELOID LEUKEMIA – TREATMENT EFFICACY IN INELIGIBLE FOR INTENSIVE CHEMOTHERAPY – SINGLE CENTER EXPERIENCE

EHA Library, Yanitsa Davidkova, 421274

OUTCOMES OF INTERMEDIATE DOSE CYTARABINE CONSOLIDATION THERAPY IN YOUNG ADULT ACUTE MYELOID LEUKEMIA: INSIGHTS FROM A DEVELOPING COUNTRY

EHA Library, Kmar Mrad, 421276

CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA DURING ACUTE MYELOBLASTIC LEUKEMIA: CLINICAL, MICROBIOLOGICAL, THERAPEUTIC AND EVOLUTIVE PROFILE

EHA Library, Hela Sahbeni, 421278

VENETOCLAX AND SORAFENIB ARE EFFECTIVE IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA WITH REFRACTORY CENTRAL NERVOUS SYSTEM INVOLVEMENT

EHA Library, Andrey Sokolov, 421280

UTILITY OF ECHOCARDIOGRAM IN NEUTROPENIC PATIENTS WITH GRAM POSITIVE BACTEREMIA – A RETROSPECTIVE STUDY

EHA Library, Neta Sternbach, 421282

UTILITY OF BASELINE CT CHEST SCREENING FOR DIAGNOSIS OF TUBERCULOUS INFECTION(TIS) IN NEWLY DIAGNOSED ADULT ACUTE MYELOID LEUKEMIA(ND AML) IN AN ENDEMIC REGION - A TERTIARY CARE EXPERIENCE

EHA Library, sabitha paramasivam, 421284

ACUTE LEUKEMIA PARTICULARITIES IN PATIENTS WITH A HISTORY OF BREAST CANCER

EHA Library, Meilin Omer, 421286

TEMPORAL CHANGES OF GUT MICROBIOTA-HOST METABOLIC CROSS TALK AND PREDICT CLINICAL OUTCOMES OF PATIENTS WITH AML

EHA Library, Jianda Hu, 421288

MOLECULAR-GENETIC PROFILE AND DIFFERENT PROGNOSTIC IMPACT OF RECURRENT GENE MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ekaterina Motyko, 421290

CYTOGENETIC SUBCLONE BURDEN: A NEW BIOMARKER PREDICTING CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS OUTCOME

EHA Library, Mona Mansour, 421292

NEXT GENERATION SEQUENCING IN CHRONIC LYMPHOCYTIC LEUKEMIA: PRELIMINARY RESULTS OF CLONAL MONITORING. EXPERIENCE OF THE ALICANTE HEMATOLOGICAL DIAGNOSIS GROUP.

EHA Library, Rocio Gonzalez-Martinez, 421296

COBBLL1 GENE AS A PREDICTIVE FACTOR OF RESPONSE IN NEWLY DIAGNOSED FIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH NON-MUTANT TP53 AND MUTANT IGHV

EHA Library, Maher Salamoon, 421298

MOLECULAR STABILITY AND KINETICS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA DURING IBRUTINIB TREATMENT

EHA Library, Sólja Remisdóttir Veyhe, 421300

THE IMPORTANCE OF PCR ANALYSIS OF IGH AND TCR-Γ GENE REARRANGEMENTS ON RICHTER TRANSFORMATION.

EHA Library, CARMEN HERERO CARRASCO, 421302

CELESTIAL-TNCLL: AN ONGOING, OPEN-LABEL, MULTIREGIONAL, PHASE 3 STUDY OF SONROTOCLAX (BGB-11417) + ZANUBRUTINIB VS VENETOCLAX + OBINUTUZUMAB FOR TREATMENT-NAIVE (TN) CLL

EHA Library, Piers Patten, 421304

A PHASE 2 STUDY EVALUATING DOSE MODIFICATION APPROACHES FOR IBRUTINIB MONOTHERAPY OR IBRUTINIB+VENETOCLAX COMBINATION IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: TAILOR

EHA Library, Paolo Ghia, 421307

REPEATED COVID-19 EVENTS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Sara Pepe, 421309

TRIAL IN PROGRESS: PROSPECTIVE STUDY OF FIXED-DURATION IBRUTINIB+VENETOCLAX (IBR+VEN) FOR FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN A REAL-WORLD SETTING: THE REALITY STUDY

EHA Library, Paolo Ghia, 421311

RECENT PATTERNS OF CARE WITH BTK INHIBITORS AND DISTRIBUTION OF SOCIAL DETERMINANTS OF HEALTH AMONG PATIENTS WITH CLL/SLL IN THE US COMMUNITY SETTING

EHA Library, David J. Andorsky, 421312

TREATMENT RESULTS WITH FLUDARABINE CYCLOPHOSPHAMIDE AND RITUXIMAB AS FIRST LINE THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS IN ALBANIA

EHA Library, Rozita Çaka, 421313

THE IMPACT OF HIGH AND LOW BURDEN TP53 MUTATION ON RISK AND TREATMENT DECISION IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Maher Salamoon, 421314

CORRELATION BETWEEN PROGRESSION FREE SURVIVAL AND OVERALL SURVIVAL AMONG PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA: A CLINICAL TRIAL-BASED APPROACH

EHA Library, Vikalp Maheshwari, 421315

REAL WORLD INCIDENCE OF TOXICITY FROM VENETOCLAX IN CLL

EHA Library, Sabrina Habib, 421316

SARS-COV-2 AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLINICAL AND IMMUNOLOGICAL OBSERVATIONS OF A REGIONAL CLINICAL REGISTER BETWEEN 2020 AND 2023

EHA Library, Dietrich KÄMPFE, 421317

HAIRY CELL LEUKEMIA: RETROSPECTIVE AND DESCRIPTIVE STUDY OF 7 PATIENTS

EHA Library, Nourhene Guedri, 421318

LONG TERM EFFICACY AND SAFETY OF IBRUTINIB: A SINGLE CENTER EXPERIENCE

EHA Library, Svilena Atanasova, 421319

ASSOCIATION OF TP53 MUTATION WITH BINET STAGE, ABSOLUTE LYMPHOCYTE COUNT AND  LYMPHOCYTE DOUBLING TIME IN B CELL CHRONIC LYMPHOCYTIC LEUKEMIA: A TERTIARY CARE CENTER EXPERIENCE FROM PAKISTAN.

EHA Library, Syeda Mah Ali, 421320

IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN A CHINESE REAL-WORLD SETTING

EHA Library, Shenmiao Yang, 421321